Aptevo Therapeutics (APVO) Total Debt (2015 - 2022)
Aptevo Therapeutics (APVO) posted Total Debt of $3.5 million for Q4 2022, down 11.61% sequentially from $3.9 million in Q3 2022, and down 77.52% YoY from $15.4 million in Q4 2021.
Aptevo Therapeutics (APVO) Total Debt (2015 - 2022) Analysis & Trends
Aptevo Therapeutics has reported Total Debt for 8 years, with the latest figure at $3.5 million in Q4 2022.
- Quarterly Total Debt fell 77.52% year-over-year to $3.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $3.5 million (down 77.52% YoY) and the FY2022 annual result came in at $3.5 million, down 77.52% from the prior year.
- Total Debt slipped to $3.5 million in Q4 2022 per APVO's latest filing, from $3.9 million in the prior quarter.
- Over five years, Total Debt peaked at $25.2 million in Q3 2020 and troughed at $3.5 million in Q4 2022.
- A 5-year average of $15.7 million and a median of $19.2 million in 2018 frame the typical range for Total Debt.
- The sharpest annual moves came in 2020 and 2022: Total Debt advanced 27.87% in 2020, then sank 77.52% in 2022.
- Over 5 years, Total Debt stood at $19.3 million in 2018, then increased by 3.03% to $19.9 million in 2019, then increased by 26.13% to $25.1 million in 2020, then plunged by 38.64% to $15.4 million in 2021, then tumbled by 77.52% to $3.5 million in 2022.
- According to Business Quant data, Total Debt over the past three periods registered $3.5 million, $3.9 million, and $4.4 million for Q4 2022, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Aptevo Therapeutics | 3.30 Mn | -6.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.46 Mn |
| Sep 30, 2022 | 3.91 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 15.37 Mn |
| Sep 30, 2021 | 15.18 Mn |
| Jun 30, 2021 | 14.99 Mn |
| Mar 31, 2021 | 14.78 Mn |
| Dec 31, 2020 | 25.05 Mn |
| Sep 30, 2020 | 25.20 Mn |
| Dec 31, 2019 | 19.86 Mn |
| Sep 30, 2019 | 19.71 Mn |
| Jun 30, 2019 | 19.56 Mn |
| Mar 31, 2019 | 19.42 Mn |
| Dec 31, 2018 | 19.28 Mn |
| Sep 30, 2018 | 19.14 Mn |
| Jun 30, 2018 | 19.57 Mn |
| Mar 31, 2018 | 19.31 Mn |
| Dec 31, 2017 | 19.06 Mn |
| Sep 30, 2017 | 17.48 Mn |